The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Emerging Strategies of Cancer Therapy Based on Ferroptosis
Open accessAbstract
Ferroptosis, a new form of regulated cell death that is iron‐ and reactive oxygen species dependent, has attracted much attention in the research communities of biochemistry, oncology, and especially material sciences. Since the first demonstration in 2012, a series of strategies have been developed to induce ferroptosis of cancer cells, including the use of nanomaterials, clinical drugs, experimental compounds, and genes. A plethora of research work has outlined the blueprint of ferroptosis as a new option for cancer therapy. However, the published ferroptosis‐related reviews have mainly focused on the mechanisms and pathways of ferroptosis, which motivated this contribution to bridge the gap between biological significance and material design. Therefore, it is timely to summarize the previous efforts on the emerging strategies for inducing ferroptosis and shed light on future directions for using such a tool to fight against cancer. Here, the current strategies of cancer therapy based on ferroptosis will be elaborated, the design considerations and the advantages and limitations are highlighted, and finally a future perspective on this emerging field is given.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Introduction to Metal–Organic Frameworks
Zhou, H.-C., Long, J. R., & Yaghi, O. M. (2012) · Chemical Reviews · doi:10.1021/cr300014x · Cited by 7,720
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2239 · Cited by 4,293
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
LXXIII.—Oxidation of tartaric acid in presence of iron
Fenton, H. J. H. (1894) · J. Chem. Soc., Trans. · doi:10.1039/ct8946500899 · Cited by 3,179
Non-crystalline Structure in Solidified Gold–Silicon Alloys
KLEMENT, W., WILLENS, R. H., & DUWEZ, P. (1960) · Nature · doi:10.1038/187869b0 · Cited by 2,808
The role of iron and reactive oxygen species in cell death
Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381
Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., et al. (2014) · eLife · doi:10.7554/elife.02523 · Cited by 2,088
Glutaminolysis and transferrin regulate ferroptosis
Gao, M., Monian, P., Quadri, N., Ramasamy, R., & Jiang, X. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.011 · Cited by 2,069
Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28251 · Cited by 2,012
Ferroptosis is an autophagic cell death process
Gao, M., Monian, P., Pan, Q., Zhang, W., Xiang, J., & Jiang, X. (2016) · Cell Research · doi:10.1038/cr.2016.95 · Cited by 1,899
Yang, W. S., & Stockwell, B. R. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.02.010 · Cited by 1,876
Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J. S., Nejadnik, H., Goodman, S., Moseley, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.168 · Cited by 1,647
RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels
Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A. J., Yang, W. S., Fridman, D. J., Wolpaw, A. J., Smukste, I., Peltier, J. M., Boniface, J. J., et al. (2007) · Nature · doi:10.1038/nature05859 · Cited by 1,631
Oxidation of tartaric acid in presence of iron
Fenton, H. J. H. (1894) · Journal of the Chemical Society (Resumed) · Cited by 1,498
Seiler, A., Schneider, M., Förster, H., Roth, S., Wirth, E. K., Culmsee, C., Plesnila, N., Kremmer, E., Rådmark, O., Wurst, W., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.005 · Cited by 1,470
Dolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
Zhang, C., Bu, W., Ni, D., Zhang, S., Li, Q., Yao, Z., Zhang, J., Yao, H., Wang, Z., & Shi, J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510031 · Cited by 1,269
Sindrilaru, A., Peters, T., Wieschalka, S., Baican, C., Baican, A., Peter, H., Hainzl, A., Schatz, S., Qi, Y., Schlecht, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44490 · Cited by 1,100
Identification of ACSL4 as a biomarker and contributor of ferroptosis
Yuan, H., Li, X., Zhang, X., Kang, R., & Tang, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.124 · Cited by 1,071
Lewerenz, J., Hewett, S. J., Huang, Y., Lambros, M., Gout, P. W., Kalivas, P. W., Massie, A., Smolders, I., Methner, A., Pergande, M., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4391 · Cited by 978
Ferroptosis, a new form of cell death, and its relationships with tumourous diseases
Yu, H., Guo, P., Xie, X., Wang, Y., & Chen, G. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13008 · Cited by 710
Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis
Sun, X., Niu, X., Chen, R., He, W., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28574 · Cited by 703
T cell lipid peroxidation induces ferroptosis and prevents immunity to infection
Matsushita, M., Freigang, S., Schneider, C., Conrad, M., Bornkamm, G. W., & Kopf, M. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140857 · Cited by 672
HSPB1 as a novel regulator of ferroptotic cancer cell death
Sun, X., Ou, Z., Xie, M., Kang, R., Fan, Y., Niu, X., Wang, H., Cao, L., & Tang, D. (2015) · Oncogene · doi:10.1038/onc.2015.32 · Cited by 666
Roh, J.-L., Kim, E. H., Jang, H., & Shin, D. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.010 · Cited by 662
Ma, P., Xiao, H., Yu, C., Liu, J., Cheng, Z., Song, H., Zhang, X., Li, C., Wang, J., Gu, Z., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04269 · Cited by 649
Regulated necrosis: disease relevance and therapeutic opportunities
Conrad, M., Angeli, J. P. F., Vandenabeele, P., & Stockwell, B. R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.6 · Cited by 630
Kim, S. E., Zhang, L., Ma, K., Riegman, M., Chen, F., Ingold, I., Conrad, M., Turker, M. Z., Gao, M., Jiang, X., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.164 · Cited by 622
Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells
Ma, S., Henson, E. S., Chen, Y., & Gibson, S. B. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.208 · Cited by 622
Basit, F., van Oppen, L. M., Schöckel, L., Bossenbroek, H. M., van Emst-de Vries, S. E., Hermeling, J. C., Grefte, S., Kopitz, C., Heroult, M., HGM Willems, P., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.133 · Cited by 565
Zille, M., Karuppagounder, S. S., Chen, Y., Gough, P. J., Bertin, J., Finger, J., Milner, T. A., Jonas, E. A., & Ratan, R. R. (2017) · Stroke · doi:10.1161/strokeaha.116.015609 · Cited by 526
Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells
Eling, N., Reuter, L., Hazin, J., Hamacher-Brady, A., & Brady, N. R. (2015) · Oncoscience · doi:10.18632/oncoscience.160 · Cited by 524
Oxytosis: a novel form of programmed cell death
Shirlee Tan, B. S. P., David Schubert, B. S. P., & Pamela Maher, B. S. P. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013394741 · Cited by 522
CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation
Yuan, H., Li, X., Zhang, X., Kang, R., & Tang, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.034 · Cited by 504
Iron and ferroptosis: A still ill‐defined liaison
Doll, S., & Conrad, M. (2017) · IUBMB Life · doi:10.1002/iub.1616 · Cited by 468
Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression
Wang, S.-J., Li, D., Ou, Y., Jiang, L., Chen, Y., Zhao, Y., & Gu, W. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.022 · Cited by 462
Li, W.-P., Su, C.-H., Chang, Y.-C., Lin, Y.-J., & Yeh, C.-S. (2016) · ACS Nano · doi:10.1021/acsnano.5b06175 · Cited by 437
Passive targeting of nanoparticles to cancer: A comprehensive review of the literature
BAZAK, R., HOURI, M., ACHY, S. E., HUSSEIN, W., & REFAAT, T. (2014) · Molecular and Clinical Oncology · doi:10.3892/mco.2014.356 · Cited by 435
Switching Apoptosis to Ferroptosis: Metal–Organic Network for High-Efficiency Anticancer Therapy
Zheng, D.-W., Lei, Q., Zhu, J.-Y., Fan, J.-X., Li, C.-X., Li, C., Xu, Z., Cheng, S.-X., & Zhang, X.-Z. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04060 · Cited by 434
Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors.
Lachaier, E., Louandre, C., Godin, C., Saidak, Z., Baert, M., Diouf, M., Chauffert, B., & Galmiche, A. (2014) · PubMed · Cited by 420
The x cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases
Lo, M., Wang, Y., & Gout, P. W. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21366 · Cited by 399
Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells
Ooko, E., Saeed, M. E. M., Kadioglu, O., Sarvi, S., Colak, M., Elmasaoudi, K., Janah, R., Greten, H. J., & Efferth, T. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.08.002 · Cited by 387
Activatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer Therapy
Zhou, Z., Song, J., Tian, R., Yang, Z., Yu, G., Lin, L., Zhang, G., Fan, W., Zhang, F., Niu, G., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201701181 · Cited by 387
Self-citationLouandre, C., Marcq, I., Bouhlal, H., Lachaier, E., Godin, C., Saidak, Z., François, C., Chatelain, D., Debuysscher, V., Barbare, J.-C., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.11.014 · Cited by 374
BID links ferroptosis to mitochondrial cell death pathways
Neitemeier, S., Jelinek, A., Laino, V., Hoffmann, L., Eisenbach, I., Eying, R., Ganjam, G. K., Dolga, A. M., Oppermann, S., & Culmsee, C. (2017) · Redox Biology · doi:10.1016/j.redox.2017.03.007 · Cited by 363
Valente, L. J., Gray, D. H. D., Michalak, E. M., Pinon-Hofbauer, J., Egle, A., Scott, C. L., Janic, A., & Strasser, A. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.012 · Cited by 291
Lin, R., Zhang, Z., Chen, L., Zhou, Y., Zou, P., Feng, C., Wang, L., & Liang, G. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.033 · Cited by 291
Heat stress induces ferroptosis-like cell death in plants
Distéfano, A. M., Martin, M. V., Córdoba, J. P., Bellido, A. M., D’Ippólito, S., Colman, S. L., Soto, D., Roldán, J. A., Bartoli, C. G., Zabaleta, E. J., et al. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201605110 · Cited by 268
A Mitochondrial-Targeted Nitroxide Is a Potent Inhibitor of Ferroptosis
Krainz, T., Gaschler, M. M., Lim, C., Sacher, J. R., Stockwell, B. R., & Wipf, P. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00199 · Cited by 235
Oxidations of iron(II)/(III) by hydrogen peroxide: from aquo to enzyme
Dunford, H. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00024-3 · Cited by 222
Recent Progress in Light-Triggered Nanotheranostics for Cancer Treatment
Zhang, P., Hu, C., Ran, W., Meng, J., Yin, Q., & Li, Y. (2016) · Theranostics · doi:10.7150/thno.15217 · Cited by 211
Kempen, P. J., Greasley, S., Parker, K. A., Campbell, J. C., Chang, H.-Y., Jones, J. R., Sinclair, R., Gambhir, S. S., & Jokerst, J. V. (2015) · Theranostics · doi:10.7150/thno.11389 · Cited by 206
Five-Membered Ring Peroxide Selectively Initiates Ferroptosis in Cancer Cells
Abrams, R. P., Carroll, W. L., & Woerpel, K. A. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00900 · Cited by 187
Shen, J., Kim, H.-C., Su, H., Wang, F., Wolfram, J., Kirui, D., Mai, J., Mu, C., Ji, L.-N., Mao, Z.-W., et al. (2014) · Theranostics · doi:10.7150/thno.8263 · Cited by 177
Yu, X., & Long, Y. C. (2016) · Scientific Reports · doi:10.1038/srep30033 · Cited by 170
Multifunctional Iron Oxide Nanoparticles for Diagnostics, Therapy and Macromolecule Delivery
Yen, S. K., Padmanabhan, P., & Selvan, S. T. (2013) · Theranostics · doi:10.7150/thno.4827 · Cited by 166
Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth
Schöckel, L., Glasauer, A., Basit, F., Bitschar, K., Truong, H., Erdmann, G., Algire, C., Hägebarth, A., Willems, P. H., Kopitz, C., et al. (2015) · Cancer & Metabolism · doi:10.1186/s40170-015-0138-0 · Cited by 161
Wu, X., Xia, Y., Huang, Y., Li, J., Ruan, H., Chen, T., Luo, L., Shen, Z., & Wu, A. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b07205 · Cited by 146
Self-citationD'Herde, K. G. M. A., & Krysko, D. V. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2261 · Cited by 145
Sehm, T., Fan, Z., Ghoochani, A., Rauh, M., Engelhorn, T., Minakaki, G., Dörfler, A., Klucken, J., Buchfelder, M., Eyüpoglu, I. Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8651 · Cited by 134
Wang, Y., Chen, J., Yang, B. Y., Qiao, H., Gao, L., Su, T., Ma, S., Zhang, X., Li, X., Liu, G., et al. (2015) · Theranostics · doi:10.7150/thno.13350 · Cited by 116
Self-citationYue, L., Wang, J., Dai, Z., Hu, Z., Chen, X., Qi, Y., Zheng, X., & Yu, D. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00562 · Cited by 99
Self-citationSu, Y., Fang, J., Liao, C.-Y., Lin, C.-T., Li, Y.-T., & Hu, S. (2015) · Theranostics · doi:10.7150/thno.12843 · Cited by 93
A galactosamine-mediated drug delivery carrier for targeted liver cancer therapy
Shen, Z., Wei, W., Tanaka, H., Kohama, K., Ma, G., Dobashi, T., Maki, Y., Wang, H., Bi, J., & Dai, S. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.06.015 · Cited by 83
Self-citationFerroptosis in p53-dependent oncosuppression and organismal homeostasis
Galluzzi, L., Pedro, J. M. B., & Kroemer, G. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.54 · Cited by 77
Rubio‐Navarro, A., Carril, M., Padró, D., Guerrero‐Hue, M., Tarín, C., Samaniego, R., Cannata, P., Cano, A., Amaro-Villalobos, J. M., Sevillano, Á., et al. (2016) · Theranostics · doi:10.7150/thno.14915 · Cited by 65
To be, or not to be: functional dilemma of p53 metabolic regulation
Wang, S.-J., & Gu, W. J. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000024 · Cited by 59
Ma, X., Gong, A., Xiang, L., Chen, T., Gao, Y., Liang, X., Shen, Z., & Wu, A. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20648c · Cited by 59
Self-citationShen, Z., Wu, H., Yang, S., Ma, X., Li, Z., Tan, M., & Wu, A. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.022 · Cited by 56
Self-citationIroning out how p53 regulates ferroptosis
Murphy, M. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615159113 · Cited by 47
Yi, H., Wang, Z.-Y., Li, X., Yin, M., Wang, L., Aldalbahi, A. K., El-Sayed, N. N. E., Wang, H., Chen, N., Fan, C., et al. (2016) · Theranostics · doi:10.7150/thno.16127 · Cited by 30
Cited by
Targeting Ferroptosis to Iron Out Cancer
Hassannia, B., Vandenabeele, P., & Vanden Berghe, T. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.002 · Cited by 2,478
Ferroptosis: machinery and regulation
Chen, X., Li, J., Kang, R., Klionsky, D. J., & Tang, D. (2021) · Autophagy · doi:10.1080/15548627.2020.1810918 · Cited by 2,099
Self-citationFerroptosis, a new form of cell death: opportunities and challenges in cancer
Mou, Y., Wang, J., Wu, J., He, D., Zhang, C., Duan, C., & Li, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0720-y · Cited by 1,930
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Recent Progress in Ferroptosis Inducers for Cancer Therapy
Liang, C., Zhang, X., Yang, M., & Dong, X. (2019) · Advanced Materials · doi:10.1002/adma.201904197 · Cited by 1,569
Metadata
- Authors
- Shen, Z., Song, J., Yung, B. C., Zhou, Z., Wu, A., & Chen, X.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2018-01-22
- Volume
- 30
- Issue
- 12
- Pages
- e1704007-e1704007
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2786943354
- Cited by
- 740
- References
- 76
- FWCI
- 47.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.